Veritable, L.P. Penumbra Inc Transaction History

Veritable, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$271.54 - $344.06 $8,689 - $11,009	-32 Reduced 2.91%	1,068 $367,000
Q1 2023 May 12, 2023	SELL	$220.43 - $278.69 $4,629 - $5,852	-21 Reduced 1.87%	1,100 $306,000
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $170,257 - $256,148	1,121 New	1,121 $249,000
Q2 2022 Aug 15, 2022	SELL	$116.09 - $227.33 $156,953 - $307,350	-1,352 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$187.51 - $283.98 $59,815 - $90,589	319 Added 30.88%	1,352 $300,000
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $245,936 - $297,504	1,033 New	1,033 $297,000
Q1 2021 May 17, 2021	SELL	$175.6 - $291.43 $226,875 - $376,527	-1,292 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$174.98 - $272.83 $226,074 - $352,496	1,292 New	1,292 $226,000

387

29.5M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.91B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.